Colgate-Palmolive Company (NYSE:CL) will provide a live video webcast of its 2025 Annual Meeting of Stockholders on Friday, May 9, 2025 at 10:00 a.m. ET.

Investors may access the live video webcast at www.virtualshareholdermeeting.com/CL2025. Access will be available beginning at 9:30 a.m. ET. For those unable to participate during the live webcast, a recorded version of the webcast will be made available on the Company’s website approximately 24 hours after the meeting concludes.

Colgate-Palmolive’s first quarter 2025 financial results

Colgate’s net sales declined by 3.1 percent, primarily due to a 4.4 percent negative impact from foreign exchange. However, organic sales grew by 1.4 percent, with growth partially offset by a 0.4 percent drop due to lower private label pet volumes.

GAAP earnings per share rose 2 percent to 0.85 dollars. Base Business EPS, which excludes certain items, increased 6 percent to 0.91 dollars.

Both GAAP and Base Business gross profit margins improved by 80 basis points, reaching 60.8 percent.

The company generated 600 million dollars in net cash from operations during the first quarter.

Colgate maintained its global leadership in oral care, with a 40.9 percent share in toothpaste and a 31.9 percent share in manual toothbrushes.

The company also updated its full-year 2025 financial guidance, although specific figures were not included in this release.

Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 first quarter earnings conference call on Friday, April 25, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate’s website at https://investor.colgatepalmolive.com/events-and-presentations.

Colgate-Palmolive has announced its agreement to acquire Care TopCo Pty Ltd, the owner of the Prime100 pet food brand, as part of its growth strategy focused on expanding into faster-growing product segments. The acquisition, set to enhance the company’s Hill’s Pet Nutrition division, marks its entry into the fresh pet food market while strengthening its presence in Australia.

Prime100, based in Melbourne, is a leading fresh pet food brand that offers refrigerated and shelf-stable products. Since its launch in 2014, it has gained recognition for its science-backed product lines and veterinarian endorsements.

Colgate-Palmolive Chairman, President, and CEO Noel Wallace highlighted Prime100’s strong positioning as a premium brand that aligns with the company’s long-term pet nutrition growth strategy. John Hazlin, President of Hill’s Pet Nutrition, emphasized the benefits of adding Prime100’s products to Hill’s portfolio, allowing for a more comprehensive offering of advanced, vet-recommended nutrition.

The acquisition, expected to close in the second quarter of 2025 pending regulatory approval in Australia, will be financed through a combination of debt and cash. The transaction is not expected to have a material impact on Colgate-Palmolive’s diluted earnings per share in 2025.

Legal and financial advisors for the deal include Wachtell, Lipton, Rosen & Katz and BofA Securities for Colgate-Palmolive, while Prime100 was advised by Gilbert + Tobin and Houlihan Lokey.

Colgate-Palmolive reported its fourth-quarter and full-year 2024 results, highlighting strong organic sales growth and improved profitability.

For the full year, net sales exceeded $20 billion for the first time, increasing by 3.3%, while organic sales grew by 7.4%. GAAP earnings per share (EPS) rose by 27% to $3.51, and base business EPS increased by 11% to $3.60. The company generated $4.1 billion in operating cash flow, up 10% from 2023, and returned $3.4 billion to shareholders through dividends and share repurchases.

In the fourth quarter, net sales remained flat at $4.94 billion, while organic sales grew by 4.3%. GAAP EPS increased by 3% to $0.90, and base business EPS rose by 5% to $0.91. Gross profit margins improved by 70 basis points to 60.3%. Colgate maintained its global market leadership in toothpaste, with a 41.4% share, and in manual toothbrushes, with a 32.2% share.

By region, Latin America saw a 7.2% decline in net sales but recorded a 9.2% increase in organic sales. Europe and Asia Pacific achieved net sales growth of 4.9% and 3.7%, respectively. North America saw a 1% decrease in net sales but a 0.7% decline in organic sales. The Hill’s Pet Nutrition segment posted a 2.3% increase in net sales and a 2.9% increase in organic sales.

Looking ahead to 2025, the company expects flat net sales due to a mid-single-digit negative impact from foreign exchange. Organic sales growth is forecasted within the long-term target range of 3-5%, factoring in the planned exit from private label pet nutrition. On both a GAAP and non-GAAP basis, Colgate expects gross profit margin expansion and low to mid-single-digit EPS growth.

CEO Noel Wallace emphasized Colgate's ability to deliver peer-leading growth while continuing to invest in brand health, innovation, and digital transformation. The company increased advertising spending by 15% in 2024, following a 19% increase in 2023, reinforcing its commitment to long-term growth.

Colgate will hold a conference call today at 8:30 a.m. ET to discuss the results.

Colgate-Palmolive Company announced its financial results for the third quarter of 2024. Key highlights include:

- Net sales grew by 2.4% to $5.03 billion, with organic sales increasing by 6.8%.
- GAAP earnings per share (EPS) rose 5% to $0.90, while base business EPS grew 6% to $0.91.
- The gross profit margin improved to 61.1% (GAAP) and 61.3% (non-GAAP), reflecting a 260-270 basis point increase from the prior year.
- Advertising expenses increased 16%, supporting innovation and brand growth.
- Year-to-date net cash provided by operations reached $2.84 billion.

Colgate maintained its global leadership in toothpaste and manual toothbrushes, holding market shares of 41.6% and 32.3%, respectively.

Updated guidance for 2024 reflects:
- Net sales growth expected at 3%-5% (up from 2%-5%), with a mid-single-digit negative impact from foreign exchange.
- Organic sales growth revised to 7%-8% (from 6%-8%).
- Continued gross profit margin expansion and double-digit EPS growth on both GAAP and non-GAAP bases, with base business EPS growth now forecasted at 10%-11%.

Segment performance showed varied results:
- North America saw a 2.1% decline in net sales, while Europe and Asia Pacific achieved 8% and 6.3% growth, respectively.
- The Hill’s pet nutrition segment reported a 6.3% sales increase and a 28% rise in operating profit.

Operating profit grew 4% on a GAAP basis to $1.07 billion and 5% on a non-GAAP basis to $1.08 billion. The gross profit margin and operating profit margin continued to expand, driven by pricing and operational efficiencies.

CEO Noel Wallace highlighted the strong results across all divisions, emphasizing the focus on household penetration, brand investment, and digital capabilities to sustain growth.